Canadian Phase I

MCI Onehealth Reports 30% Increase in Revenue, On Track for Record Year in Patient Visits

Retrieved on: 
Monday, May 16, 2022
Physician, Company, Job demands-resources model, NOT, EBITDA, Medicine, List of diplomatic missions of the United States, CHS, News, Patient, Polyclinic, Health, Mission statement, Insurance, Tet offensive attack on US Embassy, Government, FOR, COVID-19, Practitioner, MCI, Data, NEWS, TSX, COVID-19 testing, Metrolinx, Growth, Canadian Phase I, Foundation, WIRE, Precision medicine, Software as a service, Acquisition, Record, CEO, GLOBE, Fine chemical, Bank, Pharmaceutical industry

TORONTO, May 16, 2022 (GLOBE NEWSWIRE) -- MCI Onehealth Technologies Inc. (“MCI” or the “Company”) (TSX: DRDR), a clinician-led healthcare technology company focused on increasing access to and quality of healthcare, today released its financial results for the three- month period ended March 31, 2022.

Key Points: 
  • Quarterly revenue of $13.0 million, on track for another record year in multiple business units.
  • Pipeline of up to $4 million worth of projects for health data insights expected from launch of MCIs data lake.
  • The financing is available to the Company upon request to ensure the Company executes on its strategic business plan.
  • The Companys concierge health care offering continues to add members organically, including a 12% increase in membership in the first quarter.

MCI Onehealth Completes Strategic Acquisition of Polyclinic

Retrieved on: 
Thursday, August 5, 2021
Company, Chief executive officer, Efficiency, Research, MCI, Forward-looking statement, Canadian Securities Administrators, News, For, Phrase, Ministry of Health (Saudi Arabia), Earnings before interest, taxes, depreciation and amortization, Technology, Canada, Patient, Not, Wire, Legislation, Artificial intelligence, Association, Leadership, IR, Precision medicine, Intelligence, Toronto Stock Exchange, Canadian Phase I, Income, Ecosystem, Ministry, Ownership, Acquisition, Physician, Quality control, GLOBE, Medicine, Medical device, Healthcare, Medical imaging, Hospital, Health insurance, Fused quartz

TORONTO, Aug. 04, 2021 (GLOBE NEWSWIRE) -- MCI Onehealth Technologies Inc. (“MCI” or the “Company”) (TSX: DRDR) has completed a series of share purchase agreements to acquire an 80% interest in Canadian Phase Onward Inc., The Quit Clinic Inc. and Executive Medical Concierge Canada (2021) Ltd. (collectively, “Polyclinic”) through its subsidiary MCI Polyclinic Group Inc. (“MCI Polyclinic”). This strategic acquisition aligns with MCI’s mission to meaningfully contribute to the transformation of the Canadian healthcare system and improve access to care by delivering an innovative, personalized patient experience.

Key Points: 
  • MCI Polyclinic is expected to generate annualized gross revenue in excess of $5.0 million and annualized adjusted EBITDA in excess of $1.0 million.
  • The internal patient referral system in operation at MCI Polyclinic and across the MCI network helps capture the needs of patients who would otherwise struggle to find timely, specialized care.
  • MCI Polyclinic is the centralized physical example of the personalized healthcare model we have strategically built across the MCI ecosystem both digitally and physically.
  • Patients of MCI Polyclinic will continue to receive the same excellent care and convenience they have had at Polyclinic, and will now have access to additional services in the MCI network.